Matches in Wikidata for { <http://www.wikidata.org/entity/Q94602045> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q94602045 description "article scientifique publié en 2020" @default.
- Q94602045 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q94602045 description "scientific article published on 01 May 2020" @default.
- Q94602045 description "wetenschappelijk artikel" @default.
- Q94602045 description "наукова стаття, опублікована 1 травня 2020" @default.
- Q94602045 name "A multicenter, phase 2 study to evaluate the efficacy and safety of osilodrostat, a new 11β-hydroxylase inhibitor, in Japanese patients with endogenous Cushing's syndrome other than Cushing's disease" @default.
- Q94602045 name "A multicenter, phase 2 study to evaluate the efficacy and safety of osilodrostat, a new 11β-hydroxylase inhibitor, in Japanese patients with endogenous Cushing's syndrome other than Cushing's disease" @default.
- Q94602045 type Item @default.
- Q94602045 label "A multicenter, phase 2 study to evaluate the efficacy and safety of osilodrostat, a new 11β-hydroxylase inhibitor, in Japanese patients with endogenous Cushing's syndrome other than Cushing's disease" @default.
- Q94602045 label "A multicenter, phase 2 study to evaluate the efficacy and safety of osilodrostat, a new 11β-hydroxylase inhibitor, in Japanese patients with endogenous Cushing's syndrome other than Cushing's disease" @default.
- Q94602045 prefLabel "A multicenter, phase 2 study to evaluate the efficacy and safety of osilodrostat, a new 11β-hydroxylase inhibitor, in Japanese patients with endogenous Cushing's syndrome other than Cushing's disease" @default.
- Q94602045 prefLabel "A multicenter, phase 2 study to evaluate the efficacy and safety of osilodrostat, a new 11β-hydroxylase inhibitor, in Japanese patients with endogenous Cushing's syndrome other than Cushing's disease" @default.
- Q94602045 P1433 Q94602045-74C515B6-BC43-46DF-A520-F466385FEEF8 @default.
- Q94602045 P1476 Q94602045-B367DC5F-0AEC-4A68-BB78-B16F24A0BD3B @default.
- Q94602045 P2093 Q94602045-031711F6-A836-49E3-8DCC-AE8D280FBCAA @default.
- Q94602045 P2093 Q94602045-04C0A5BD-1F78-4352-85E9-894ABB87FCCB @default.
- Q94602045 P2093 Q94602045-1503486F-FEDE-441B-B446-404CA619F2B5 @default.
- Q94602045 P2093 Q94602045-1CC9E551-CECA-46C3-A333-769C1DD7CFF2 @default.
- Q94602045 P2093 Q94602045-360013E0-6D4D-4AFA-990F-9BB55DCAB2A9 @default.
- Q94602045 P2093 Q94602045-5CD68C83-2F75-4D68-A773-99BDF4CC0D5E @default.
- Q94602045 P2093 Q94602045-634144C3-9ABF-4782-A4A4-E125E2800DB2 @default.
- Q94602045 P2093 Q94602045-7F0ADDCD-D608-4B0E-BB1F-50406977EC5A @default.
- Q94602045 P2093 Q94602045-949B7F11-AF8E-4EE7-891A-73436E85A88F @default.
- Q94602045 P31 Q94602045-9EA23C03-3599-4830-A057-016D5BC115C5 @default.
- Q94602045 P356 Q94602045-A1EBEAAD-0373-4C6E-8196-5C8E9BB52559 @default.
- Q94602045 P577 Q94602045-4C89F52C-60C2-4663-8FFC-965E80CCA415 @default.
- Q94602045 P698 Q94602045-67371B16-A685-4305-B98C-8681B8C060AF @default.
- Q94602045 P921 Q94602045-1D62907C-0037-4494-9E7D-687231966295 @default.
- Q94602045 P921 Q94602045-A512A67C-A1DC-422B-88C4-F643F76953D1 @default.
- Q94602045 P356 ENDOCRJ.EJ19-0617 @default.
- Q94602045 P698 32378529 @default.
- Q94602045 P1433 Q5376304 @default.
- Q94602045 P1476 "A multicenter, phase 2 study to evaluate the efficacy and safety of osilodrostat, a new 11β-hydroxylase inhibitor, in Japanese patients with endogenous Cushing's syndrome other than Cushing's disease" @default.
- Q94602045 P2093 "Akina Suzuki" @default.
- Q94602045 P2093 "Akira Shimatsu" @default.
- Q94602045 P2093 "Fumitoshi Satoh" @default.
- Q94602045 P2093 "Makoto Ujihara" @default.
- Q94602045 P2093 "Masahiko Sato" @default.
- Q94602045 P2093 "Sanae Midorikawa" @default.
- Q94602045 P2093 "Tamami Takeda" @default.
- Q94602045 P2093 "Tomoaki Tanaka" @default.
- Q94602045 P2093 "Tomomi Kaneko" @default.
- Q94602045 P31 Q13442814 @default.
- Q94602045 P356 "10.1507/ENDOCRJ.EJ19-0617" @default.
- Q94602045 P577 "2020-05-01T00:00:00Z" @default.
- Q94602045 P698 "32378529" @default.
- Q94602045 P921 Q1947304 @default.
- Q94602045 P921 Q219102 @default.